MDFI promotes the proliferation and tolerance to chemotherapy of colorectal cancer cells by binding ITGB4/LAMB3 to activate the AKT signaling pathway,Cancer Biology & Therapy

当前位置： X-MOL 学术 › Cancer Biol. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

MDFI promotes the proliferation and tolerance to chemotherapy of colorectal cancer cells by binding ITGB4/LAMB3 to activate the AKT signaling pathway
Cancer Biology & Therapy ( IF 3.6 ) Pub Date : 2024-02-20 , DOI: 10.1080/15384047.2024.2314324
Ding Ma _{1,

2} , Shuwen Liu ₁ , Kua Liu ₁ , Lingkai Kong ₁ , Lingjun Xiao ₁ , Qilei Xin ₃ , Chunping Jiang _{1,

3} , Junhua Wu _{1,

3}

Affiliation

Colorectal cancer (CRC) is one of the most lethal cancers. Single-cell RNA sequencing (scRNA-seq) and protein-protein interactions (PPIs) have enabled the systematic study of CRC. In our research, ...

中文翻译：